Hertility CEO Helen O’Neill on Building a Foundational Model for Women’s Health

Why It Matters

Accelerating endometriosis diagnosis reduces years of patient suffering and lowers long‑term healthcare costs, positioning Hertility as a catalyst for systemic change in women’s health. The model showcases how AI can overcome data‑collection barriers, opening new market opportunities for tech‑enabled reproductive care.

Key Takeaways

• Hertility diagnoses endometriosis with 98‑99% confidence in eight days
• UK faces 700,000 women waiting for gynecological care
• Foundational AI model targets menstrual-cycle data collection challenges
• Hertility offers telemedicine, ultrasounds, IVF, and egg‑freezing services
• Company pivots from simple startup to complex investor‑ready pretzel

Pulse Analysis

The UK’s women’s health landscape has long suffered from under‑investment and data gaps, leaving roughly 700,000 women on waiting lists for gynecological care. Historically, clinical trials have excluded women, and the logistical challenge of gathering precise menstrual‑cycle data at scale has hampered research progress. This systemic neglect contributes to delayed diagnoses, particularly for conditions like endometriosis, where patients often endure a decade of symptoms before receiving a definitive answer.

Hertility’s breakthrough lies in its AI‑powered diagnostic platform that captures third‑day menstrual data and integrates it with remote clinical services. By leveraging machine‑learning models trained on thousands of cycle profiles, the company can pinpoint endometriosis with near‑perfect confidence within eight days—a stark contrast to the NHS’s nine‑year average. Beyond diagnosis, Hertility offers a full suite of reproductive solutions, from telemedicine consultations and high‑resolution ultrasounds to IVF cycles and egg‑freezing, creating a seamless patient journey that reduces friction and accelerates treatment timelines.

The broader implications extend to investors and policymakers alike. Hertility’s shift from a “baguette” startup to a “pretzel”‑shaped, investor‑ready enterprise demonstrates the scalability of data‑centric health models. As AI continues to lower barriers to high‑quality female health data, the market for tech‑enabled fertility and gynecological services is poised for rapid expansion. Stakeholders should watch how Hertility’s approach could inform public‑private partnerships, drive regulatory reforms, and ultimately reshape the economics of women’s healthcare in the UK and beyond.